top of page

Our versatile platform technology is a beacon of hope for patients in great need.

Empowering Lives with Unique CNS-directed Therapeutics

COMPACT CELLULAR INNOVATION Small hollow fiber device loaded with genetically engineered myoblast cells

A best in class, patented, platform technology

for the local and targeted delivery of highly potent therapeutic proteins to the CNS and beyond.

ABOUT OUR TECHNOLOGY

Treating genetic disorders without gene therapies

3

tested products

5

patents

2

awards

Dedicated Team Pioneering Therapeutic Technological Advancements

ABOUT US

We're on a mission to get therapeutic proteins where they are needed most, in the CNS and beyond.

OUR MISSION

Our vision is to treat genetic disorders of the CNS without gene therapy.

OUR VISION

Our team has been instrumental in advancing in allogeneic encapsulated cell therapy from early research to a transformative solution for disorders of the CNS.  

OUR TEAM

Collaborating with world-leading neurology research centres and cell therapy CDMOs, we're heralding a new era of hope for patients and their families around the world.

OUR SUPPORT

HOW IT WORKS

Decoding Our Therapeutic Technology

Treatment areas:

CNS hereditary diseases, focusing on Metachromatic Leukodystrophy (MLD).

Latest Insights

NEWS

OUR PARTNERS

Innovative Partnerships Advancing Therapeutic Solutions

Happy healthy family

Curious to learn how our technology will transform your investment goals?

Be part of the next big breakthrough in CNS disorders.

bottom of page